KGN: Wound Dressing With Animal-Derived Material(S)
What it covers
FDA’s classification database gives KGN no definition, and the code has no classification regulation. Its name is “Wound Dressing With Animal-Derived Material(S)”; the recent clearances below show what has been cleared under it.
FDA flags KGN devices as implants.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K260530 | epi-ConneKt Wound Matrix | MLM Biologics, Inc. | Oct 15, 2026 | Traditional |
| K260652 | ColActive Plus | Covalon Technologies, Ltd. | Sep 9, 2026 | Traditional |
| K260711 | Accelagen Plus Surgical Matrix, 1cc (CG-01AP);Accelagen Plus Surgical Matrix, 3cc (CG-03AP);Accelagen Plus Surgical Matrix, 5cc (CG-05AP);Accelagen Plus Surgical Strip, 125x25x2mm (CG-125X25AP);Accelagen Plus Surgical Strip, 250x25x2mm (CG-250X25AP) | Berkeley Advanced Biomaterials | Aug 27, 2026 | Traditional |
| K260596 | Collagen Wound Powder | Ventris Medical | Jul 2, 2026 | Traditional |
| K260669 | Endoform Dermal Template | Aroa Biosurgery , Ltd. | Jun 24, 2026 | Traditional |
| K253521 | ECMT-100 WMD | Ecm Therapeutics, Inc. | Jun 18, 2026 | Traditional |
| K253204 | Catalyze | BioTissue Holdings, Inc. | Jun 5, 2026 | Traditional |
| K254034 | Roosin Collagen Powder | Roosin Medical Co., Ltd. | Jun 3, 2026 | Traditional |
| K253974 | Roosin Collagen Dressing | Roosin Medical Co., Ltd. | Jun 3, 2026 | Traditional |
| K261224 | MatriDerm | Medskin Solutions Dr. Suwelack AG | May 14, 2026 | Special |
Clearances by year
122 KGN 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 14 | 172 |
| 2025 | 10 | 162 |
| 2024 | 13 | 83 |
| 2023 | 9 | 194 |
| 2022 | 12 | 246 |
| 2021 | 6 | 236 |
| 2020 | 5 | 279 |
| 2019 | 3 | 128 |
| 2018 | 6 | 148 |
| 2017 | 7 | 136 |
| 2016 | 4 | 164 |
| 2015 | 7 | 87 |
| 2014 | 5 | 188 |
| 2013 | 6 | 147 |
| 2012 | 8 | 123 |
| 2011 | 7 | 228 |
Who submits
66 applicants cleared a KGN device since 2011. 66% of the clearances went to applicants in United States, then China (7%), Switzerland (4%) and Iceland (4%). By type: Traditional 81% and Special 19%.
| Applicant | Clearances since 2011 |
|---|---|
| Acell, Inc. | 9 |
| Geistlich Pharma AG | 5 |
| Kerecis Limited | 5 |
| Bionova Medical, Inc. | 4 |
| Collagen Matrix, Inc. | 4 |
| Reprise Biomedical, Inc. | 4 |
| Triad Life Sciences, Inc. | 4 |
| Aroa Biosurgery , Ltd. | 3 |
Standards
KGN has no classification regulation naming standards. Check FDA’s recognized standards database, or ask which standards recent KGN clearances declared.
Ask about KGN
Questions about KGN
What is FDA product code KGN?
Product code KGN, “Wound Dressing With Animal-Derived Material(S)” in FDA's classification database, is an unclassified device type, reviewed by FDA's Unknown panel. FDA's 510(k) database lists 193 clearances under KGN, 122 of them since 2011.
How many 510(k) clearances are there under KGN?
FDA’s 510(k) database listed 193 clearances under KGN as of Oct 29, 2026, 122 of them decided since 2011; the most recent decision was Oct 15, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a KGN 510(k)?
For the 26 KGN clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 158 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most KGN clearances?
Since 2011: Acell, Inc. (9), Geistlich Pharma AG (5), Kerecis Limited (5), Bionova Medical, Inc. (4) and Collagen Matrix, Inc. (4). 66 applicants have cleared a KGN device in that time.